Practice Economics

SGR cuts pay by 21%; CMS to hold checks for 2 weeks


 

References

Medicare physician pay was cut by approximately 21% effective April 1, due to the expiration of the last temporary fix to the Sustainable Growth Rate formula.

Because legislation to repeal the SGR has passed the House and awaits action in the Senate, the Centers for Medicare & Medicaid Services announced it will hold Medicare payments for 2 weeks, allowing Congress to complete action on the issue.

© crazydiva/Thinkstock

Without a legislative fix, beginning April 15, “CMS will begin processing claims received on or after April 1 with a 21% reduction in the physician’s rate to limit the impact on Medicare providers and beneficiaries,” the agency said in a statement.

The House on March 26 overwhelming passed H.R.2, the Medicare Access and CHIP Reauthorization Act, which would repeal the SGR, reauthorize the Children’s Health Insurance Program for 2 years, and reform Medicare. The Senate did not address the bill before taking a recess until April 13.

Should SGR repeal legislation pass Congress and be signed by the President – something he has indicated he will do – CMS will reprocess any claims processed at the lower rate.

gtwachtman@frontlinemedcom.com

Recommended Reading

Medicare advisers: Cancer prognostic tests not ready for prime time
MDedge Hematology and Oncology
CMS: Stage 3 meaningful use by 2018
MDedge Hematology and Oncology
House votes to repeal SGR, reauthorize CHIP
MDedge Hematology and Oncology
Doctors hail House vote to repeal, replace SGR
MDedge Hematology and Oncology
Senate recesses without addressing SGR repeal bill
MDedge Hematology and Oncology
Commonwealth Fund: ACA’s medical loss ratio rule saves $5 billion
MDedge Hematology and Oncology
Supreme Court won’t hear IPAB challenge
MDedge Hematology and Oncology
New team of experts to guide Precision Medicine Initiative
MDedge Hematology and Oncology
Supreme Court: Docs cannot sue over low Medicaid payments
MDedge Hematology and Oncology
Vaccine pioneer begins reign as acting director of the National Cancer Institute
MDedge Hematology and Oncology